Perivesical inflammation and necrosis due to mitomycin C instillation after transurethral resection of bladder tumor: we must be vigilant! 2009

Adem Fazlioglu, and Zafer Tandogdu, and Fatih Osman Kurtulus, and Oguzhan Parlakkilic, and Mete Cek
Urology Department, Taksim Teaching Hospital, Istanbul, Turkey.

The instillation of chemotherapeutic agents after transurethral resection of bladder tumor as an adjuvant treatment in bladder tumors is accepted as being safe if there is no associated bladder perforation. Mitomycin C (MMC) is a widely used agent for the adjuvant treatment of bladder tumors. A patient who developed MMC-induced bladder perforation and perivesical necrosis after an uneventful endoscopic tumor is presented. We suggest that the possible reason for such a complication could be deep resection at the anterior bladder wall. The treatment of the situation continued for an extended period, causing serious discomfort for the patient. Withholding immediate intravesical MMC instillation after resection of tumors on the anterior bladder wall ought to be considered in the early postoperative hours.

UI MeSH Term Description Entries
D008297 Male Males
D009336 Necrosis The death of cells in an organ or tissue due to disease, injury or failure of the blood supply.
D011183 Postoperative Complications Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery. Complication, Postoperative,Complications, Postoperative,Postoperative Complication
D001743 Urinary Bladder A musculomembranous sac along the URINARY TRACT. URINE flows from the KIDNEYS into the bladder via the ureters (URETER), and is held there until URINATION. Bladder,Bladder Detrusor Muscle,Detrusor Urinae,Bladder Detrusor Muscles,Bladder, Urinary,Detrusor Muscle, Bladder,Detrusor Muscles, Bladder
D001749 Urinary Bladder Neoplasms Tumors or cancer of the URINARY BLADDER. Bladder Cancer,Bladder Neoplasms,Cancer of Bladder,Bladder Tumors,Cancer of the Bladder,Malignant Tumor of Urinary Bladder,Neoplasms, Bladder,Urinary Bladder Cancer,Bladder Cancers,Bladder Neoplasm,Bladder Tumor,Cancer, Bladder,Cancer, Urinary Bladder,Neoplasm, Bladder,Neoplasm, Urinary Bladder,Tumor, Bladder,Tumors, Bladder,Urinary Bladder Neoplasm
D003556 Cystitis Inflammation of the URINARY BLADDER, either from bacterial or non-bacterial causes. Cystitis is usually associated with painful urination (dysuria), increased frequency, urgency, and suprapubic pain. Cystitides
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000283 Administration, Intravesical The instillation or other administration of drugs into the bladder, usually to treat local disease, including neoplasms. Bladder Drug Administration,Drug Administration, Bladder,Instillation, Bladder,Intravesical Drug Administration,Administration, Intravesical Drug,Injections, Intravesical,Intravesical Administration,Intravesical Injection,Intravesical Instillation,Administration, Bladder Drug,Administrations, Bladder Drug,Administrations, Intravesical,Administrations, Intravesical Drug,Bladder Drug Administrations,Bladder Instillation,Bladder Instillations,Drug Administration, Intravesical,Drug Administrations, Bladder,Drug Administrations, Intravesical,Injection, Intravesical,Instillation, Intravesical,Instillations, Bladder,Instillations, Intravesical,Intravesical Administrations,Intravesical Drug Administrations,Intravesical Injections,Intravesical Instillations
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial

Related Publications

Adem Fazlioglu, and Zafer Tandogdu, and Fatih Osman Kurtulus, and Oguzhan Parlakkilic, and Mete Cek
March 2000, BJU international,
Adem Fazlioglu, and Zafer Tandogdu, and Fatih Osman Kurtulus, and Oguzhan Parlakkilic, and Mete Cek
December 2006, The Canadian journal of urology,
Adem Fazlioglu, and Zafer Tandogdu, and Fatih Osman Kurtulus, and Oguzhan Parlakkilic, and Mete Cek
April 2014, Scandinavian journal of urology,
Adem Fazlioglu, and Zafer Tandogdu, and Fatih Osman Kurtulus, and Oguzhan Parlakkilic, and Mete Cek
March 2011, Anticancer research,
Adem Fazlioglu, and Zafer Tandogdu, and Fatih Osman Kurtulus, and Oguzhan Parlakkilic, and Mete Cek
February 2011, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie,
Adem Fazlioglu, and Zafer Tandogdu, and Fatih Osman Kurtulus, and Oguzhan Parlakkilic, and Mete Cek
April 2012, The Journal of urology,
Adem Fazlioglu, and Zafer Tandogdu, and Fatih Osman Kurtulus, and Oguzhan Parlakkilic, and Mete Cek
January 2006, Urology journal,
Adem Fazlioglu, and Zafer Tandogdu, and Fatih Osman Kurtulus, and Oguzhan Parlakkilic, and Mete Cek
January 2018, Case reports in cardiology,
Adem Fazlioglu, and Zafer Tandogdu, and Fatih Osman Kurtulus, and Oguzhan Parlakkilic, and Mete Cek
March 2016, Urology,
Adem Fazlioglu, and Zafer Tandogdu, and Fatih Osman Kurtulus, and Oguzhan Parlakkilic, and Mete Cek
July 1984, The Journal of urology,
Copied contents to your clipboard!